<?xml version="1.0" encoding="UTF-8"?>
<p>Hepatitis E is endemic in many Middle Eastern countries (Turkey, Yemen, Libya, Oman, Bahrain, Iran, Kuwait, Saudi Arabia, and the United Arab Emeritus) [
 <xref rid="B21-viruses-12-00553" ref-type="bibr">21</xref>], some regions of Southeast Asia (Thailand, Singapore) [
 <xref rid="B22-viruses-12-00553" ref-type="bibr">22</xref>], and South America (Brazil, Argentina, Ecuador, and Uruguay) [
 <xref rid="B23-viruses-12-00553" ref-type="bibr">23</xref>]. Hepatitis E is responsible for more than a quarter of all cases of acute intermittent hepatitis and impending hepatitis, however, jaundice epidemics caused by HEV infection do not occur in such areas [
 <xref rid="B24-viruses-12-00553" ref-type="bibr">24</xref>]. The epidemiology of HEV in Egypt is distinct and different from the rest of the world, the disease occurs at a young age. The HEV that affects the Egyptian population is the HEV-1 genotype, with subtypes that are not found in the Asian population [
 <xref rid="B25-viruses-12-00553" ref-type="bibr">25</xref>,
 <xref rid="B26-viruses-12-00553" ref-type="bibr">26</xref>].
</p>
